{
    "clinical_study": {
        "@rank": "45038", 
        "arm_group": [
            {
                "arm_group_label": "Ketamine", 
                "arm_group_type": "Experimental", 
                "description": "Subject will receive 6 infusions of ketamine over three weeks."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subjects will receive 6 infusions of normal saline over 3 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "Ketamine infusions resulted in an acute reduction in global depression scores and in\n      severity of suicidal ideation. The investigators therefore plan to investigate the\n      feasibility and efficacy of repeated intravenous administration of ketamine in severely\n      depressed, treatment resistant patients. The results of the study could lead to development\n      of new strategies for treating depression."
        }, 
        "brief_title": "Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Major Depressive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Depressive Disorder", 
                "Depression", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Outpatient with sever treatment resistant depression\n\n          -  Currently depressed\n\n          -  Currently under regular psychiatric care\n\n          -  On an aggressive antidepressant regimen, stable for 4 weeks.\n\n        Exclusion Criteria:\n\n          -  No history of other major psychiatric illness, including bipolar\n\n          -  No history of psychosis\n\n          -  No history of drug abuse\n\n          -  No major medical illness or unstable medical problem"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01667926", 
            "org_study_id": "2012-P-001042"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ketamine", 
                "description": "ketamine infusions twice a week for three weeks, total of 6 infusions as augmentation of ongoing antidepressant regimen.", 
                "intervention_name": "Ketamine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ketamine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Depression Clinical and Reseach Program - MGH"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Double-blind Ketamine Augmentation in Chronically Suicidal, Treatment-resistant Major Depression", 
        "overall_official": {
            "affiliation": "MGH Department of Psychiatry", 
            "last_name": "Cristina Cusin, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subjects will be assessed with HAM-D", 
            "measure": "Hamilton Depression Rating Scale - 28 Items", 
            "safety_issue": "No", 
            "time_frame": "up to 4 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01667926"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Cristina Cusin, MD", 
            "investigator_title": "Instructor HSM", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Subjects will be monitored for emergence of side effects weekly for the first 8 weeks and then every two weeks for 8 weeks.", 
            "measure": "Systematic Assessment for Treatment Emergent Events (SAFTEE)", 
            "safety_issue": "Yes", 
            "time_frame": "up to 5 months"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}